Zyprexa and Weight abnormal - a phase IV clinical study of FDA data
Summary:
We study 62,725 people who have side effects when taking Zyprexa. Weight abnormal is found, especially among people who are female, 40-49 old, have been taking the drug for 2 - 5 years, also take Seroquel and have Schizophrenia.
The phase IV clinical study analyzes which people take Zyprexa and have Weight abnormal. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
62,725 people reported to have side effects when taking Zyprexa.
Among them, 1,686 people (2.69%) have Weight abnormal.
What is Zyprexa?
Zyprexa has active ingredients of olanzapine. It is used in bipolar disorder. Currently, eHealthMe is studying from 64,021 Zyprexa users.
What is Weight abnormal?
Weight abnormal is found to be associated with 2,465 drugs and 1,213 conditions by eHealthMe. Currently, we are studying 2,583 people who have Weight abnormal.
Number of Zyprexa and Weight abnormal reports submitted per year:
Time on Zyprexa when people have Weight abnormal *:
Gender of people who have Weight abnormal when taking Zyprexa*:
Age of people who have Weight abnormal when taking Zyprexa *:
Common drugs people take besides Zyprexa *:
Common side effects people have besides Weight abnormal *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zyprexa and have Weight abnormal?
Check whether Weight abnormal is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Related studies
Zyprexa side effects by duration, gender and age:
- Zyprexa side effects (64,021 reports)
Weight abnormal treatments and more:
- Weight abnormal (2,583 reports)
Common drugs associated with Weight abnormal:
- Risperdal: 4,813 reports
- Prednisone: 2,635 reports
- Seroquel: 2,287 reports
- Risperidone: 2,103 reports
- Humira: 1,885 reports
- Zyprexa: 1,686 reports
- Methotrexate: 1,520 reports
- Metformin: 1,486 reports
- Aspirin: 1,324 reports
- Enbrel: 1,293 reports
All the drugs that are associated with Weight abnormal:
- Weight abnormal (2,465 drugs)
Common conditions associated with Weight abnormal:
- Depression: 2,107 reports
- Bipolar disorder: 1,919 reports
- Rheumatoid arthritis: 1,884 reports
- Schizophrenia: 1,869 reports
- High blood pressure: 1,417 reports
- Attention deficit hyperactivity disorder: 1,354 reports
All the conditions that are associated with Weight abnormal:
- Weight abnormal (1,213 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Renagel and Hyperphosphataemia - 10 seconds ago
- Guaifenesin and Hydrochlorothiazide drug interaction - 34 seconds ago
- Buspar and Pancreatitis - 38 seconds ago
- Nasacort and Cytoxan drug interaction - 51 seconds ago
- Myrbetriq and Atenolol drug interaction - 58 seconds ago
- Keflex and Night Sweats - a minute ago
- Zometa and Acute Bilateral Obstructive Uropathy - a minute ago
- Liothyronine Sodium and Tarceva drug interaction - a minute ago
- Sustiva and Thrombocytopenia - 2 minutes ago
- Valium and Reading Disorder - 2 minutes ago